Legal Representation
Attorney
Pollie Gautsch, Esq.
USPTO Deadlines
Next Deadline
616 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210928)
Due Date
September 28, 2027
Grace Period Ends
March 28, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 6, 2026 | PRAM | O | POST REGISTRATION ACTION MAILED - SEC. 7 | Loading... |
| Dec 4, 2025 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | Loading... |
| Dec 2, 2025 | PRAM | O | POST REGISTRATION ACTION MAILED - SEC. 7 | Loading... |
| Dec 2, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Sep 16, 2025 | ES7R | I | TEAS SECTION 7 REQUEST RECEIVED | Loading... |
| Dec 23, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 23, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 23, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 23, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Dec 23, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 28, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 4, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 29, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 29, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jul 29, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 29, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 13, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 13, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 23, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 9, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 8, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 8, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 3, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 5, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 2, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 2, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 2, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 2, 2020 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Nov 18, 2020 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Nov 12, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 11, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 11, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 20, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 20, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 20, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 13, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 3, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 9, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Compiling indexes of information relevant to financial investment decisions
Class 036
Providing stock market information; financial analysis and information services; financial analysis and information services, namely, providing information to investors about the timing of the results of clinical trials for pharmaceuticals to aid investors in making financial investment decisions; providing investors with financial information relevant to financial investment decisions; information, advisory, consultancy and research services relating to finance and investments; providing financial analysis of pharmaceutical companies listed on the U.S. stock market, for investment purposes; providing financial analysis of pharmaceutical companies listed on the U.S. stock market, for research purposes; providing investment information relating to pharmaceutical development; any of the aforementioned services when provided via a website or via a newsletter
Class 042
Providing medical and scientific research information about the results of clinical trials for pharmaceuticals; analysis of technical pharmaceutical research data; provision of information and data relating to medical and veterinary research and development; providing information relating to pharmaceutical development including the results of clinical trials and pending clinical trial data of ongoing trials, for research purposes; any of the aforementioned services when provided via a website or via a newsletter
Classification
International Classes
035
036
042